Alexander Weich
Impact in
Papers in
- Oncology 30
- Lung Cancer Research Studies 15
- Peptidase Inhibition and Analysis 7
- Chemokine receptors and signaling 5
- Epidemiology 21
- Neuroendocrine Tumor Research Advances 21
- Co-authors
- Rudolf A. Werner (36 shared papers)Andreas K. Buck (31 shared papers)Takahiro Higuchi (29 shared papers)Constantin Lapa (18 shared papers)Steven P. Rowe (13 shared papers)Martin G. Pomper (9 shared papers)Andreas Schirbel (11 shared papers)Sebastian E. Serfling (26 shared papers)
- Journals
- Journal of Nuclear Medicine (7 papers)Molecular Imaging and Biology (5 papers)European Journal of Nuclear Medicine and Molecular Imaging (4 papers)Theranostics (2 papers)Cancers (2 papers)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Alexander Weich
41 papers receiving 578 citations
Peers
Comparison fields: 5 of 59
- Oncology 366
- Neurology 132
- Radiology, Nuclear Medicine and Imaging 160
- Epidemiology 205
- Cancer Research 54
Countries citing papers authored by Alexander Weich
This map shows the geographic impact of Alexander Weich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Weich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Weich more than expected).
Fields of papers citing papers by Alexander Weich
This network shows the impact of papers produced by Alexander Weich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Weich. The network helps show where Alexander Weich may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Weich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 79 | |
| 2 | 2022 | 55 | |
| 3 | 2018 | 54 | |
| 4 | 2018 | 53 | |
| 5 | 2013 | 39 | |
| 6 | 2018 | 37 | |
| 7 | 2022 | 34 | |
| 8 | 2021 | 27 | |
| 9 | 2019 | 24 | |
| 10 | 2022 | 22 | |
| 11 | 2023 | 19 | |
| 12 | 2016 | 15 | |
| 13 | 2016 | 11 | |
| 14 | 2022 | 10 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2023 | 7 | |
| 19 | 2023 | 6 | |
| 20 | 2023 | 6 |
About Alexander Weich
Alexander Weich is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Neurology and Surgery, having authored 48 papers that have together received 582 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (21 papers), Lung Cancer Research Studies (15 papers), Neuroblastoma Research and Treatments (11 papers), Peptidase Inhibition and Analysis (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Chemokine receptors and signaling (5 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). The work is most often cited by research in Oncology (366 citations), Neurology (132 citations), Radiology, Nuclear Medicine and Imaging (160 citations), Epidemiology (205 citations) and Cancer Research (54 citations). Alexander Weich has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Rudolf A. Werner, Andreas K. Buck, Takahiro Higuchi, Constantin Lapa, Steven P. Rowe, Martin G. Pomper, Andreas Schirbel, Sebastian E. Serfling, Mehrbod S. Javadi and Philipp E. Hartrampf. Their work appears in journals such as Journal of Nuclear Medicine, Molecular Imaging and Biology, European Journal of Nuclear Medicine and Molecular Imaging, Theranostics and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.